PreviousNext
123456

Friends Research Institute is a multidisciplinary, non-profit research institution dedicated to advancing research to promote health and well-being.

For over 70 years, FRI scientists have conducted cutting edge research in the fields of substance use, health, mental health, HIV/AIDS, and criminal justice. FRI has a long history of research on the prevention and treatment of substance use disorders, as well as the broader societal impacts of addiction.

Currently, the FRI portfolio spans clinical trials of pharmacological and behavioral treatments, epidemiological investigations, technology-based interventions, health services research, and implementation science.

SPOTLIGHT ON RESEARCH

Karen Alexander and Courtney Norkeck

Drs. Karen Alexander and Courtney Nordeck Receive R01 Award

FRI is pleased to announce that Drs. Karen Alexander and Courtney Nordeck (MPIs) have received an R01 award from the National Institute on Nursing Research for their project, titled “A Patient Navigation Trial for Housing and Health (PATHH): A randomized controlled trial.”
Read more

NEWS

FRI-Logo-2025-V2-1

FRI Celebrates 70 years

FRI proudly celebrates its 70th anniversary this year! This milestone marks seven decades of advancing science and improving lives. Founded in 1955 in Baltimore, Maryland as “Friends of Psychiatric Research,” FRI began as a small community-based organization focused on improving the quality of care of individuals with mental illness. In the ensuing years, FRI broadened its scope to address the intersecting challenges of substance use, health, and involvement in the criminal legal system. For seven decades, FRI investigators and staff have conducted groundbreaking work on some of the nation’s most vexing health and social problems. This work has helped to shape scientific understanding, clinical practice, and policy in the areas of addiction, mental health, HIV/AIDS, and criminal justice reform.
Read more

PUBLICATIONS

Alexander, K., Sharma, A., Fletcher, J. B., Smith, Z., Huddleston, T., Gryczynski, J., & Stitzer, M. (2025). Digitally delivered contingency management during methadone treatment for people with co-occurring cocaine and opioid use: a protocol for a randomized controlled trial Frontiers in Psychiatry 16, 1576277. https://doi.org/10.3389/fpsyt.2025.1576277
Sawyer-Morris, G., Halverson, M., Maher, K. M., Carswell, S. B., & Gordon, M. S. (2025). Implementing real-time assessments of substance use cravings, triggers, and mood: a feasibility study with justice-involved populations Health & Justice 13(1), 60
Blue, T. R., Gordon, M. S., Vocci, F. J., Fishman, M. J., Gwin Mitchell, S., & Wenzel, K. (2025). A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine. Journal of addiction medicine, 10.1097/ADM.0000000000001430. Advance online publication. https://doi.org/10.1097/ADM.0000000000001430
Cullins, Z., Ross, A., Beckwith, C. G., Gordon, M., Blue, T., Black, C., Camp, H., & Brinkley-Rubinstein, L. (2025). Staff perspectives on using long-acting antiretroviral treatment among persons being released from carceral settings in Baltimore, Maryland, USA AIDS care 1–7. Advance online publication.

All publications >

© Copyright - Friends Research Institute.